(Q33492086)

27 July 2017

title

Predictors of toxicity in treating patients with neuroblastoma by radiolabeled metaiodobenzylguanidine (English)

1 reference

27 July 2017

1 reference

J C Sisson

1

1 reference

27 July 2017

B Shapiro

2

1 reference

27 July 2017

R J Hutchinson

3

1 reference

27 July 2017

J E Carey

4

1 reference

27 July 2017

K R Zasadny

5

1 reference

27 July 2017

S A Zempel

6

1 reference

27 July 2017

D P Normolle

7

1 reference

27 July 2017

publication date

1 January 1994

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

27 July 2017

published in

1 reference

27 July 2017

volume

21

1 reference

27 July 2017

issue

1

1 reference

27 July 2017

page(s)

46-52

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00182305

27 July 2017

exact match

0 references

cites work

131Imetaiodobenzylguanidine in neuroblastoma patients at diagnosis

1 reference

12 December 2020

Modeling and dosimetry of monoclonal antibody M195 (anti-CD33) in acute myelogenous leukemia.

1 reference

12 December 2020

Treatment of neuroblastoma with [131I]metaiodobenzylguanidine: long-term results in 25 patients

1 reference

12 December 2020

Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide

1 reference

12 December 2020

Long-term results of [131I]metaiodobenzylguanidine treatment of refractory advanced neuroblastoma

1 reference

12 December 2020

Experience with palliative [131I]metaiodobenzylguanidine therapy in advanced neuroblastoma

1 reference

12 December 2020

Efficacy and safety of [131I]metaiodobenzylguanidine therapy for patients with refractory neuroblastoma

1 reference

12 December 2020

Preoperative [131I]metaiodobenzylguanidine therapy of neuroblastoma at diagnosis ("MIBG de novo")

1 reference

12 December 2020

Therapeutic use of [131I]metaiodobenzylguanidine in neuroblastoma: a phase II study in 26 patients. "Société Française d'Oncologie Pédiatrique" and Nuclear Medicine Co-investigators

1 reference

12 December 2020

Outcome of [131I]metaiodobenzylguanidine therapy of neuroblastoma: seven years after

1 reference

12 December 2020

The use of [131I]metaiodobenzylguanidine in the treatment of neuroblastoma after conventional therapy

1 reference

12 December 2020

131Imetaiodobenzylguanidine therapy in advanced neuroblastoma

1 reference

12 December 2020

[131I]metaiodobenzylguanidine and high-dose chemotherapy with bone marrow rescue in advanced neuroblastoma

1 reference

12 December 2020

The biodistribution and pharmacokinetics of meta-iodobenzylguanidine in childhood neuroblastoma

1 reference

12 December 2020

Toxicity from treatment of neuroblastoma with 131I-meta-iodobenzylguanidine

1 reference

12 December 2020

Iodine-125-MIBG to treat neuroblastoma: preliminary report

1 reference

12 December 2020

Treatment of neuroblastoma with [125I]metaiodobenzylguanidine

1 reference

12 December 2020

131Imetaiodobenzylguanidine therapy after conventional therapy for neuroblastoma

1 reference

12 December 2020

131-I-metaiodobenzylguanidine treatment in patients with refractory advanced neuroblastoma

1 reference

12 December 2020

Radiopharmaceutical treatment of malignant pheochromocytoma

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00182305

1 reference

27 July 2017

1 reference